Tenax Therapeutics Inc.

NASDAQ: TENX
Share price (12/4/25): $9.35
Market cap (12/4/25): $58.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Registration of securities for employees

Prospectus supplement

Registration of securities for employees

Ownership Filter

Giordano Christopher Thomas

Almenoff June Sherie

McGauley Thomas

Almenoff June Sherie

Venrock Healthcare Capital Partners III, L.P.

News Filter

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

Material Definitive Agreement, Financial Statements or Exhibits

Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness